Marco Caricato

Prof. Dr. Marco Caricato

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2002 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
VRValter Ripetti
Valter Ripetti
MCMarco Caricato
Marco Caricato
AAAugusto Arullani
Augusto Arullani
Stapling procedure is a new technique for the surgical management of third-degree hemorrhoids. Even if long-term experience has not been reported, this new technique is generating a lot of interest and its use is becoming more common in Europe. Some articles have just been published about severe adverse effects of this operation, and in the present article we describe a case of a life-threatening complication that occurred with the use of the stapling technique for hemorrhoidectomy. A patient with perineal descensus and third-degree hemorrhoids underwent a stapling procedure for the treatment of hemorrhoids. Retropneumoperitoneum and pneumomediastinum developed on postoperative Day 2 and a colostomy was performed, allowing a quick recovery of the patient. After six months the colostomy was closed and bowel function restored. Our experience, taken together with some other cases previously published of severe complications after such an operation, suggests caution in the use of this new technique for the treatment of a benign disease.

15 June 2007 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
MCMarco Caricato
Marco Caricato
FAF. Ausania
F. Ausania
VRV. Ripetti
V. Ripetti
FBF. Bartolozzi
F. Bartolozzi
GCG. Campoli
G. Campoli
RCRoberto Coppola
Roberto Coppola

27 November 2013 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
FPFrancesco Pantano
Francesco Pantano
PBPierpaolo Berti
Pierpaolo Berti
FGFrancesco Maria Guida
Francesco Maria Guida
Giuseppe PerroneGiuseppe Perrone
Giuseppe Perrone
BVBruno Vincenzi
Bruno Vincenzi
SDSantini Daniele
Santini Daniele
Tumour‐associated Macrophages (TAM) present two different polarizations: classical (M1) characterized by immunostimulation activity and tumour suppression; alternative (M2) characterized by tumour promotion and immune suppression. In this retrospective study, we evaluated the correlation between the two forms of TAM with survival time in radically resected gastric cancer patients. A total of 52 chemo‐ and radio‐naive patients were included. Two slides were prepared for each patient and double‐stained for CD68/NOS2 (M1) or CD68/CD163 (M2) and five representative high‐power fields per slide were evaluated for TAM count. The median value of the two macrophage populations density and the median value of M1/M2 ratio were used as cut‐off. Twenty‐seven patients with M1 density above‐the‐median had a significantly higher survival compared to those below the median. Twenty‐six patients with M1/M2 ratio above the median showed median OS of 27.2 months compared to 15.5 months of the patients below the median. No association between M2 macrophage density and patient's outcome was found. In multivariate analysis, M1/M2 was a positive independent predictor of survival. The M1 macrophage density and M1/M2 ratio, as confirmed in multivariate analysis, are factors that can help in predicting patients survival time after radical surgery for gastric cancer.

1 June 2007 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
NSNicole Suciu-Foca
Nicole Suciu-Foca
NFNikki Feirt
Nikki Feirt
QZQing-Yin Zhang
Qing-Yin Zhang
GVGeorge Vlad
George Vlad
ZLZhuoru Liu
Zhuoru Liu
RCRaffaello Cortesini
Raffaello Cortesini
Attempts to enhance patients’ immune responses to malignancies have been largely unsuccessful. We now describe an immune-escape mechanism mediated by the inhibitory receptor Ig-like transcript 3 (ILT3) that may be responsible for such failures. Using a humanized SCID mouse model, we demonstrate that soluble and membrane ILT3 induce CD8+ T suppressor cells and prevent rejection of allogeneic tumor transplants. Furthermore, we found that patients with melanoma, and carcinomas of the colon, rectum, and pancreas produce the soluble ILT3 protein, which induces the differentiation of CD8+ T suppressor cells and impairs T cell responses in MLC. These responses are restored by anti-ILT3 mAb or by depletion of soluble ILT3 from the serum. Immunohistochemical staining of biopsies from the tumors and metastatic lymph nodes suggests that CD68+ tumor-associated macrophages represent the major source of soluble ILT3. Alternative splicing, resulting in the loss of the ILT3 transmembrane domain, may contribute to the release of ILT3 in the circulation. These data suggest that ILT3 depletion or blockade is crucial to the success of immunotherapy in cancer. In contrast, the inhibitory activity of soluble ILT3 on T cell alloreactivity in vitro and in vivo suggests the potential usefulness of rILT3 for immunosuppressive treatment of allograft recipients or patients with autoimmune diseases.

1 March 2006 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
MCMarco Caricato
Marco Caricato
DBD. Borzomati
D. Borzomati
FAF. Ausania
F. Ausania
SVS. Valeri
S. Valeri
ARA. Rosignoli
A. Rosignoli
RCRoberto Coppola
Roberto Coppola

31 May 2005 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
GTG Tonini
G Tonini
BVBruno Vincenzi
Bruno Vincenzi
SDSantini Daniele
Santini Daniele
SSS Scarpa
S Scarpa
TVT Vasaturo
T Vasaturo
APA Picciocchi
A Picciocchi
Pancreatic cancer is one of the most aggressive gastrointestinal cancer with less than 10% long-term survivors. The apoptotic pathway deregulation is a postulated mechanism of carcinogenesis of this tumour. The present study investigated the prognostic role of apoptosis and apoptosis-involved proteins in a series of surgically resected pancreatic cancer patients. All patients affected by pancreatic adenocarcinoma and treated with surgical resection from 1988 to 2003 were considered for the study. Patients' clinical data and pathological tumour features were recorded. Survivin and Cox-2 expression were evaluated by immunohistochemical staining. Apoptotic cells were identified using the TUNEL method. Tumour specimen of 67 resected patients was included in the study. By univariate analysis, survival was influenced by Survivin overexpression. The nuclear Survivin overexpression was associated with better prognosis (P=0.0009), while its cytoplasmic overexpression resulted a negative prognostic factor (P=0.0127). Also, the apoptotic index was a statistically significant prognostic factor in a univariate model (P=0.0142). By a multivariate Cox regression analysis, both the nuclear (P=0.002) and cytoplasmic (P=0.040) Survivin overexpression maintained the prognostic statistical value. This is the first study reporting a statistical significant prognostic relevance of nuclear and cytoplasmic Survivin overexpression in pancreatic cancer. In particular, patients with high nuclear Survivin staining showed a longer survival, whereas patients with high cytoplasmic Survivin staining had a shorter overall survival.